Navigation Links
Strategies for translational research in the UK

A commentary published in the journal, Science Translational Medicine, examines the structures of translational research investment in the UK.

The commentary has been written by researchers from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre (BRC) at Guy's and St Thomas' and King's College London. The authors consider the results of substantial Government and charitable investment in translational research taking place within the NHS.

The commentary follows the progress of the research and development funding streams available through the NIHR. The NIHR was set up in 2006 to ensure that the highest quality research takes place within an NHS setting and that patients have the opportunity to take part.

The authors write that the NIHR Biomedical Research Centres and Biomedical Research Units, which bring together NHS hospitals and academic partners, "have created a tangible focus on translational research in the UK and an efficient interface" for scientists and clinicians to work together for the benefit of patients.

Professor Graham Lord, Deputy Director of the comprehensive BRC at Guy's and St Thomas' and King's College London, and the senior author of the paper, said: "The research centres provide a means of coordinating and producing a coherent research strategy that is focused on delivering more rapid benefits for patients."

The strategy at this centre has involved a strong focus on translational research training and career development, interdisciplinary working between clinicians and scientists working in different disease areas and disciplines, public and patient engagement, investment in leading-edge facilities and technologies, and engagement with industry. The centre underpins the work of King's Health Partners, one of only five Academic Health Sciences Centres.

The authors conclude that "in a relatively short time frame, much has been achieved in terms of establishing a cutting-edge UK translational research infrastructure" which has great potential for wealth generation. Furthermore, the UK has seen a substantial increase in the number of clinical studies taking place within the NHS over the last five years and the number of patients involved in the quest to find improved diagnostic tests and treatments for a wide range of medical conditions.


Contact: Andrea Ttofa
King's College London

Related biology news :

1. More effective weight control strategies are urgently needed
2. Self-defense strategies of moss
3. New adult malnutrition strategies could improve diagnosis and treatment
4. Drug industry embraces new business strategies after tough year
5. Male Australian redback spiders employ courtship strategies to preserve their life
6. Martin Hensen, head of e-strategies, UCB Germany: Making e-marketing more than just an add-on
7. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
8. GEN reports on strategies to overcome blood-brain barrier
9. Innovative strategies for war wounded
10. USC wins $56.8M NIH award for clinical and translational research
11. National Eye Institute hosts Translational Research and Vision Symposium
Post Your Comments:
(Date:11/19/2015)... Nov. 19, 2015  Although some 350 companies are ... by a few companies, according to Kalorama Information. These include ... of the market share of the 6.1 billion-dollar molecular ... World Market for Molecular Diagnostic s .    ... is still controlled by one company and only a ...
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... ... 2015 , ... The United States Golf Association (USGA) today announced Dr. Bruce ... Presented annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service ... , Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
Breaking Biology Technology: